Regenerative Medical Technology Group Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Regenerative Medical Technology Group Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q2 2024.
  • Regenerative Medical Technology Group Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$2.08M, a 2.29% decline year-over-year.
  • Regenerative Medical Technology Group Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$10.2M, a 68.1% decline year-over-year.
  • Regenerative Medical Technology Group Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$9.81M, a 78.2% decline from 2022.
  • Regenerative Medical Technology Group Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$5.51M, a 57.3% increase from 2021.
  • Regenerative Medical Technology Group Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$12.9M, a 119% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$10.2M -$2.08M -$46.4K -2.29% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$10.1M -$1.96M -$291K -17.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 -$9.81M -$256K +$736K +74.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-15
Q3 2023 -$10.6M -$5.86M -$4.51M -336% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$6.04M -$2.03M -$537K -36% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$5.5M -$1.67M +$6.72K +0.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q4 2022 -$5.51M -$992K +$578K +36.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-15
Q3 2022 -$6.09M -$1.34M +$8.57M +86.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$14.7M -$1.49M -$567K -61.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$14.1M -$1.68M -$1.2M -255% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 -$12.9M -$1.57M -$7.32M -127% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-14
Q3 2021 -$5.56M -$9.92M -$2.51M -33.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$3.06M -$926K +$2.46M +72.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$5.52M -$472K +$374K +44.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-19
Q4 2020 -$5.9M $5.75M +$6.78M Oct 1, 2020 Dec 31, 2020 10-K 2022-05-05
Q3 2020 -$12.7M -$7.41M -$5.67M -327% Jul 1, 2020 Sep 30, 2020 10-Q 2021-12-22
Q2 2020 -$7M -$3.39M -$6.33M -215% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$672K -$846K +$1.84M +68.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$2.51M -$1.03M +$293K +22.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-13
Q3 2019 -$2.8M -$1.73M -$1.11M -176% Jul 1, 2019 Sep 30, 2019 10-Q 2021-02-24
Q2 2019 -$1.7M $2.94M +$2.91M +8499% Apr 1, 2019 Jun 30, 2019 10-Q 2021-02-08
Q1 2019 -$4.6M -$2.68M -$2.54M -1842% Jan 1, 2019 Mar 31, 2019 10-Q 2021-01-07
Q4 2018 -$2.06M -$1.33M Oct 1, 2018 Dec 31, 2018 10-K 2020-12-09
Q3 2018 -$628K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-15
Q2 2018 $34.2K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$138K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.